Comparison
3 Phosphoglycerate Dehydrogenase Deficiency C0580190 vs 3 5 Finger Syndactyly C4023727
Clinical comparison between 3 Phosphoglycerate Dehydrogenase Deficiency and 3 5 Finger Syndactyly for differential diagnosis and treatment planning.
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
A rare metabolic disorder impairing the body's ability to produce serine, an essential amino acid. It primarily affects the nervous system, causing developmental delay, seizures, and movement difficulties. Management includes serine supplementation and anticonvulsants as needed.
3 5 Finger Syndactyly C4023727
Webbing of the third and fifth fingers present at birth. Mild cases often need no intervention; surgery can be pursued for functional or cosmetic reasons.
6 comparison axes
Onset
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
0-5
3 5 Finger Syndactyly C4023727
0-0
Onset patterns differ
Severity
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
severe
3 5 Finger Syndactyly C4023727
mild
Different severity levels
Chronic
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
Chronic
3 5 Finger Syndactyly C4023727
Chronic
Differing course
Communicable
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
No
3 5 Finger Syndactyly C4023727
No
Different transmission
Body System
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
metabolic
3 5 Finger Syndactyly C4023727
musculoskeletal
Same/different system
Category
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
metabolic
3 5 Finger Syndactyly C4023727
genetic
Different category
Bottom line
3-phosphoglycerate-dehydrogenase-deficiency-C0580190 and 3-5-finger-syndactyly-C4023727 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Phosphoglycerate Dehydrogenase Deficiency C0580190 | 3 5 Finger Syndactyly C4023727 | Discriminating power |
|---|---|---|---|
| Developmental delay | Described as a primary neurologic feature | Not expected from isolated finger webbing | High |
| Seizures | May occur and require anticonvulsant care | Not a feature of the hand finding itself | High |
| Finger webbing | Not the defining presentation | Present at birth between the third and fifth fingers | High |
When to favor each condition
Choose 3 Phosphoglycerate Dehydrogenase Deficiency C0580190 when
Early neurologic symptoms
Developmental delay, seizures, or movement difficulty suggest the metabolic condition
Moderate
Suspected serine-synthesis disorder
Clinical concern centers on impaired serine production rather than limb anatomy
Moderate
Need for metabolic evaluation
Amino-acid assessment is more relevant than hand imaging
High
Choose 3 5 Finger Syndactyly C4023727 when
Isolated congenital hand webbing
The finding is musculoskeletal and visible at birth
High
Function or appearance concern
Surgery may be considered; many mild cases need no intervention
Moderate
No neurologic features
Absence of seizures or delay makes the metabolic diagnosis less likely
Moderate
How key tests differ
| Test | 3 Phosphoglycerate Dehydrogenase Deficiency C0580190 | 3 5 Finger Syndactyly C4023727 | Interpretation |
|---|---|---|---|
| Plasma amino acids | May show low serine; exact cutoffs are not supplied | No amino-acid abnormality is expected from syndactyly alone | An abnormal result supports metabolic evaluation but is not itself a complete diagnosis |
| Neurologic assessment or EEG | May document seizures or developmental impairment | Usually not indicated for isolated finger webbing | Findings require clinician correlation and do not establish either condition alone |
| Hand examination or imaging | No characteristic finger fusion is described | Shows congenital third-to-fifth finger webbing | Anatomy distinguishes the hand finding; imaging choice depends on surgical planning |
Prognosis comparison
3 Phosphoglycerate Dehydrogenase Deficiency C0580190
- Outcome
- Potentially serious chronic neurologic disorder; exact outcome is not established
- Factors
- Seizure control, developmental course, and response to indicated metabolic care
3 5 Finger Syndactyly C4023727
- Outcome
- Often mild; function may be preserved without surgery
- Factors
- Degree of webbing and any functional or cosmetic limitation
Time frame: Left may present from birth to early childhood; right is present at birth. Long-term outcomes vary
Individual severity, associated findings, and clinician-directed management; quantitative prognosis is not supplied
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic complications | Seizures, developmental delay, and movement difficulty are described Not expected from the finger anomaly alone Severity and frequency beyond the source description are not established |
| Hand function | Not a defining issue Webbing may affect function or appearance Mild cases may need no treatment |
| Treatment-related issues | Serine supplementation and anticonvulsants may be used as clinically indicated Surgery has procedural risks if chosen Doses, indications, and outcomes are not specified here |
Patient education highlights
- HighDifferent conditions
One is a rare metabolic nervous-system disorder; the other is congenital finger webbing. A clinician should interpret the diagnosis.
- HighWhen to seek care
New seizures, developmental concerns, feeding difficulty, or worsening hand function warrant prompt clinical review.
- MediumTreatment expectations
Metabolic care may include serine and seizure treatment; syndactyly treatment ranges from observation to elective surgery.